Effects of a gliadin-combined plant superoxide dismutase extract on self-perceived fatigue in women aged 50-65 years
- PMID: 21044831
- DOI: 10.1016/j.phymed.2010.09.006
Effects of a gliadin-combined plant superoxide dismutase extract on self-perceived fatigue in women aged 50-65 years
Abstract
Fatigue syndromes exist on a continuum of severity from mild and transient to the disabling chronic fatigue syndrome, with oxidative stress linked to its pathogenesis. A thermolabile gliadin-combined plant superoxide dismutase (SOD) extract has shown potential in clinical trials as a therapeutic antioxidant. This study investigated the effects of 12 weeks of 500 mg/day of a SOD/gliadin supplement on fatigue. Thirty-eight women aged 50-65 years with self-perceived fatigue entered this randomized, double-blind, placebo-controlled trial. The primary outcome measure was general fatigue determined by the Multidimensional Fatigue Inventory (MFI). Secondary outcome measures included other measures of fatigue from the MFI and blood measures of oxidative stress, antioxidant status and hormones. There were no significant (P>0.05) differences between, or within groups, for decreases in general fatigue (active=1.6%, placebo=4.1%). There were no within or between group differences (P>0.05) in other measures of fatigue (physical fatigue, reduced activity, reduced motivation, mental fatigue and total fatigue score). In regard to the biochemical measures, there were non-significant (P>0.05) differences in increases in plasma SOD activity (active=7.1%, placebo=12.2%), plasma GPx activity (active=2.4%, placebo=0.7%), red blood cell GPx activity (active=9.8%, placebo=4.4%). Markers of oxidative stress were decreased but there were no differences (P>0.05) within or between groups; malondialdehyde (active=4.1%, placebo=1.6%), F-2 isoprostanes (active=14.7%, placebo=22.4%). There was a trend (P=0.08) for a decrease in cortisol in the active group (24.6%), however this was not significantly different from the decrease in the placebo participants (4.1%). DHEA differences were not significant (P<0.05) and declined 1.3% in the active group and 14.4% in the placebo group. In summary, the thermolabile SOD/gliadin supplement had no significant effect on self-perceived fatigue, antioxidants, oxidative stress or hormones in women aged 50-65 years.
Copyright © 2010 Elsevier GmbH. All rights reserved.
Similar articles
-
Supplementation with gliadin-combined plant superoxide dismutase extract promotes antioxidant defences and protects against oxidative stress.Phytother Res. 2004 Dec;18(12):957-62. doi: 10.1002/ptr.1542. Phytother Res. 2004. PMID: 15742357
-
Therapeutic value of oral supplementation with melon superoxide dismutase and wheat gliadin combination.Nutrition. 2015 Mar;31(3):430-6. doi: 10.1016/j.nut.2014.10.006. Epub 2014 Nov 5. Nutrition. 2015. PMID: 25701330 Review.
-
Antioxidant and anti-inflammatory properties of a Cucumis melo LC. extract rich in superoxide dismutase activity.J Ethnopharmacol. 2004 Sep;94(1):67-75. doi: 10.1016/j.jep.2004.04.023. J Ethnopharmacol. 2004. PMID: 15261965
-
[The effect of vitamin-mineral supplementation on the level of MDA and activity of glutathione peroxidase and superoxide dismutase in blood of matched maternal-cord pairs].Przegl Lek. 2004;61(7):760-3. Przegl Lek. 2004. PMID: 15792016 Clinical Trial. Polish.
-
Meta-analysis of randomized controlled trials of 4 weeks or longer suggest that curcumin may afford some protection against oxidative stress.Nutr Res. 2018 Dec;60:1-12. doi: 10.1016/j.nutres.2018.08.003. Epub 2018 Sep 4. Nutr Res. 2018. PMID: 30527253
Cited by
-
Dietary supplementation with a superoxide dismutase-melon concentrate reduces stress, physical and mental fatigue in healthy people: a randomised, double-blind, placebo-controlled trial.Nutrients. 2014 Jun 19;6(6):2348-59. doi: 10.3390/nu6062348. Nutrients. 2014. PMID: 24949549 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous